Marie-Pierre Malice

Statistics

Publications

Citations

545

H-Index

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Marie-Pierre Malice is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in allergy, pharmacotherapy, and hypersensitivity.

Publications per year

2000–2004

Publications

Montelukast for treating seasonal allergic rhinitis: a randomized, double‐blind, placebo‐controlled trial performed in the spring

George Philip, K. Malmström, Frank C. Hampel et al. · Clinical & Experimental Allergy · 2002 · 242 citations

Life Sciences, Pharmacology, Pharmacotherapy +16

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal‐salt diet

Jules I. Schwartz, K. Vandormael, Marie-Pierre Malice et al. · Clinical Pharmacology & Therapeutics · 2002 · 158 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +11

Effects of Alendronate on Bone Quality and Remodeling in Glucocorticoid-Induced Osteoporosis: A Histomorphometric Analysis of Transiliac Biopsies

Pascale Chavassieux, M. Arlot, Jean‐Paul Roux et al. · Journal of Bone and Mineral Research · 2000 · 105 citations

Medicine, Endocrinology, Bone Augmentation +16

Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure

Tamara T. Perry, Jonathan Corren, George Philip et al. · Annals of Allergy Asthma & Immunology · 2004 · 40 citations

Life Sciences, Immunology, Internal Medicine +12

1–4 of 4